Healthcare providers dont expect the Trump administrations negotiated price cuts to make much difference to consumers, because pharmaceutical companies already offer discounts
Fatime Cody Stanford, an obesity medicine physician at Mass General Brigham and associate professor at Harvard Medical School, warns that compounded versions of the drugs are not the same and they are not tested
Anderson EM, Noble ML, Garty S, Ma H, Bryers JD, Shen TT, et al
Because retatrutide has not yet received MHRA or EMA approval, it is not currently available through NHS prescriptions or licensed private clinics in the UK
Diabetic ketoacidosis (DKA) While considered lower-risk than with SGLT2 inhibitors, DKA can still occur in people with type 1 diabetes taking tirzepatide, particularly if the insulin dose is reduced too aggressively or if the person becomes unwell (e.g
Chemical irritation from the medication GLP-1 receptor agonists are not pH-neutral